TrialTranslational psychiatry2023

Artificial intelligence approach for the analysis of placebo-controlled clinical trials in major depressive disorders accounting for individual propensity to respond to placebo.

Roberto Gomeni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.